Search Results 2621-2630 of 18347 for rheumatoid arthritis
... arthritis, Cervical spine injury. Show more areas of focus for Mel D. Helgeson, M.D.. Research. Mayo Clinic researchers in the Neural Engineering and ...
Comparison of Hormone Replacement Therapy (HRT) with Traditional Risk Factor Modification Iran Journal of Obstetrics, Gynecology and Infertility.2001;7:(8):78.
... factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with everolimus in combination with exemestane ...
... arthritis, Basilar skull invagination, Neurofibromatosis type 2, Pancoast tumor, Failed back syndrome, Nerve irritation, Brachial plexus avulsion pain ...
Epub 2011 Feb 03. View PubMed; Rizza SA, Cummins NW, Rider DN, Saeed S, Klein MB, Badley AD. Polymorphism in tumor necrosis factor-related apoptosis-inducing ...
... factor for sensitivity to chemotherapy in colorectal cancer treatment. The study was published Friday, July 2, in Oncogene. "We have identified a mechanism ...
Population attributable risk (PAR) is a function of time because both the prevalence of a risk factor and its effect on exposed individuals may change over ...
Taking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment. Clinically significant ...
Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...
Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage on the ends of your bones ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.